Drugs & Targets MD Anderson and DelMar Pharmaceuticals form collaboration January 16, 2016Vol.42 No.02
Drugs & Targets Eisai submits MAA to European Medicines Agency for lenvatinib January 16, 2016Vol.42 No.02
Drugs & Targets Sorrento Therapeutics and Karolinska Institutet form collaboration January 16, 2016Vol.42 No.02
Drugs & TargetsFree Breakthrough Therapy Granted to Boehringer Ingelheim TKI Inhibitor in NSCLC January 08, 2016Vol.42 No.01
Drugs & TargetsFree Amgen enters into agreement with GSK to reclaim rights to Prolia, XGEVA, and Vectibix January 08, 2016Vol.42 No.01
Drugs & TargetsFree Stem Cell Theranostics and CapellaBio launch collaboration on cardiotoxicity January 08, 2016Vol.42 No.01
Drugs & Targets FDA Approves Opdivo Injection for Renal Cell Carcinoma Patients December 25, 2015Vol.38 No.12
Drugs & TargetsFree Amgen enters into agreement with GSK to reclaim rights to Prolia, XGEVA, and Vectibix December 18, 2015Vol.41 No.46
